ArticleERJ open research2022

Enhanced neutrophil extracellular trap formation in COVID-19 is inhibited by the protein kinase C inhibitor ruboxistaurin.

Rebecca Dowey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.